HighTide Therapeutics Inc

Company Profile

• Business description

  HighTide Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of first-in-class multifunctional, multi-targeted therapies for cardiovascular-kidney-metabolic (CKM) diseases and related metabolic disorders. The company is developing a pipeline of proprietary drug candidates targeting indications including type 2 diabetes mellitus, chronic kidney disease, obesity, metabolic dysfunction-associated steatohepatitis (MASH), and primary sclerosing cholangitis (PSC). Its core product candidate, HTD1801 (berberine ursodeoxycholate), is an orally delivered first-in-class anti-inflammatory metabolic modulator designed to target dual pathways involving AMPK activation and NLRP3 inflammasome inhibition.

• Contact

  Fubao Street
  9th to 10th Floor, Building D, Shenfang Park
  Futian District, Shenzhen-Hong Kong Science and
  Technology Innovation Cooperation Zone, Guangdong
  Shenzhen518112
  CHN

  T: +86 75521534843

  https://www.hightidetx.com

• Sector

  Healthcare

  Stock type

  Defensive

• Industry

  Biotechnology

  Fiscal Year End

  31 December 2026

  Employees

  51